Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan flag Japan · Delayed Price · Currency is JPY
295.00
-7.00 (-2.32%)
Feb 13, 2026, 3:30 PM JST

Taiko Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
14,82416,61415,08217,19335,91169,826
Market Cap Growth
-2.53%10.16%-12.28%-52.12%-48.57%4.58%
Enterprise Value
12,05914,07013,28517,03834,79061,349
Last Close Price
295.00331.00303.00394.00824.001601.01
PE Ratio
17.3718.50---16.71
Forward PE
19.90----15.59
PS Ratio
2.492.642.463.413.183.11
PB Ratio
1.802.092.242.142.803.07
P/TBV Ratio
1.812.092.242.202.873.11
P/FCF Ratio
-81.04----
P/OCF Ratio
-45.90----
PEG Ratio
-4.034.034.034.034.03
EV/Sales Ratio
2.032.242.173.383.082.73
EV/EBITDA Ratio
24.8115.88---8.89
EV/EBIT Ratio
52.8922.33---9.78
EV/FCF Ratio
-68.64----
Debt / Equity Ratio
0.120.260.480.470.370.00
Debt / EBITDA Ratio
2.102.29---0.01
Debt / FCF Ratio
-9.89----
Net Debt / Equity Ratio
-0.34-0.31-0.330.04-0.10-0.21
Net Debt / EBITDA Ratio
-5.69-2.837.38-0.130.33-0.70
Net Debt / FCF Ratio
--12.225.52-0.150.430.99
Asset Turnover
0.480.480.430.270.42-
Inventory Turnover
1.431.722.131.541.78-
Quick Ratio
2.502.442.451.902.351.72
Current Ratio
3.533.072.992.713.192.65
Return on Equity (ROE)
10.47%12.22%-48.86%-46.96%-53.92%-
Return on Assets (ROA)
1.16%3.01%-4.45%-10.24%-11.39%-
Return on Invested Capital (ROIC)
4.30%12.64%-15.65%-31.05%-33.64%32.83%
Return on Capital Employed (ROCE)
2.40%6.30%-9.90%-25.10%-27.20%25.80%
Earnings Yield
5.75%5.41%-23.94%-28.47%-26.72%5.98%
FCF Yield
-1.23%-2.68%-11.97%-8.55%-6.99%
Dividend Yield
-----1.48%
Payout Ratio
-0.11%---26.97%
Buyback Yield / Dilution
-0.25%-5.96%-8.62%-0.21%-0.35%-1.32%
Total Shareholder Return
-0.25%-5.96%-8.62%-0.21%-0.35%0.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.